Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 06/25/13 → 02/19/17 |
Funding
- Celgene Corporation: $5,875.00
A Phase 3 Multicenter Randomized Open Label Study to Compare the Efficacy & Safety of Pomalidomide, Bortezomib & Low Dose Dexamethasone Versus Bortezomib & Low-Dose Dexamethasone in Subjects with Relapsed or Refractory Multiple Myeloma
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Wood, Sylvia (CoPI)
- Kiner-Strachan, Bonnie (CoPI)
- Masood, Aisha (CoPI)
Project: Research